Op-eds How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir by: Tian Johnson, Fatima Hassan, Asia Russell and Sangeeta Shashikant
Maverick Citizen Talks have started to get the twice-yearly anti-HIV jab registered in SA by: Mia Malan
Maverick Citizen Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa by: Mia Malan and Linda Pretorius
World, Newsdeck, COVID-19 Gilead questions WHO study that cast doubts on drug's COVID-19 benefits by: Reuters
South Africa A redeeming moment for the SA government: A case for compulsory licensing in the age of Covid-19 by: Fatima Hassan